News / Business
Developer of Technology for the Treatment of Liver Maladies for Caleco Pharma Corp. (OTCBB: CAEH), Interviewed on SmallCapVoice.com
SmallCapVoice.com has announced their interview with Caleco Pharma Corp. (OTCBB: CAEH) is available to listeners visiting the site.
Listen to the audio interview with Caleco Pharma Corp.
Caleco Pharma Corp.’s business plan is to develop its proprietary technology designed to treat moderate to severe liver maladies, such as elevated liver enzymes and the Hepatitis C viral infection, (the “Liver Health Formula”) as an over-the-counter medication and as a United States Food and Drug Administration (”FDA”) approved pharmaceutical. To date, the Company’s intellectual property covering the Liver Health Formula comprises of patent applications in the United States, Europe and Canada and four European Drug Master File applications.
The audio interview with Caleco Pharma Corp. is also available on the SmallCapVoice business profile on WooEB.
SmallCapVoice is dedicated to ensuring its client companies gain valuable exposure in the small cap and OTC markets. Through internet interviews, conference calls, emails, investor newsletters, inclusion in the investment newsletter “The Small Cap Daily” and, placement on financial web sites SmallCapVoice creates a consistent presence in the public eye for their clients.
To sign up for the FREE SmallCapVoice.com daily newsletter visit http://smallcapvoice.com/newsletter.html
Contact:
Stuart T. Smith
CEO
512-267-2430
